Icahn School of Medicine at Mount Sinai’s recent national clinical dataset identified gender-based differences in specific psychiatric comorbidities for opioid, alcohol and cannabis substance use disorders. Future studies should examine biopsychosocial mechanisms that underlie these differences, to improve personalized care.


